Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Solicitation opportunity from Department Of Health And Human Services was posted on July 31, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Medicinal Chemistry Support for Therapeutic Development: Synthesis of HERV-K Protease Inhibitors

Closed
75N98026Q00906Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The National Institutes of Health is seeking commercial offerings for the synthesis of HERV-K protease inhibitors as part of medicinal chemistry support for therapeutic development, under solicitation number 75N98026Q00906. This is a competitive, firm-fixed-price acquisition conducted under FAR Subpart 12.6 as a streamlined solicitation for commercial items, with a projected value not exceeding $350,000. The government intends to award the contract to the offeror providing the best value based on technical capability, price, past performance, and delivery schedule. The work involves the design and synthesis of inhibitors targeting HERV-K protease, and responses must include full pricing details, delivery terms, F.O.B. point, product identifiers, and a clear timeline for completion after award. All offerors must be active in SAM.gov and provide their Unique Entity Identifier, Taxpayer Identification Number, and business size certification. The requirement is not set aside for small businesses, and the associated NAICS code is 541380. Proposals must be submitted electronically by August 10, 2026, at 9:00 AM Eastern Time to James Law at [email hidden] and must include the completed FAR 52.212-3 representations and certifications. The contract will be formed automatically upon written notice of award if submitted within the specified timeframe. Additional evaluation criteria may consider warranty, lifecycle costs, maintenance availability, and environmental efficiency. The place of performance is Bethesda, Maryland, and all terms and conditions are governed by FAR 52.212-4 and 52.212-5, incorporating applicable statutory and executive order requirements. Offerors are expected to demonstrate proven ability in medicinal chemistry, particularly in organic synthesis and protease inhibitor development, with the capability to deliver high-quality compounds on schedule.

General Info

NIH seeks commercial synthesis of HERV-K protease inhibitors under $350,000 firm-fixed-price contract with technical and pricing evaluation.

NAICS

541380 - Testing Laboratories and Services

Place of Performance

Bethesda, MD, 20892, USA

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao
Contacts1 person available
OfficeBETHESDA, MD, 20892, USA
Office AddressBETHESDA, MD, 20892, USA
Contacts

Full Description

Show more

COMBINED SYNOPSIS / SOLICITATION


Title: Medicinal Chemistry Support for Therapeutic Development: Synthesis of HERV-K Protease Inhibitors


This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued.


The solicitation number is 75N98026Q00906. This solicitation is issued as a competitive combined synopsis/solicitation for commercial products or commercial services. The Government intends to award a contract or purchase order resulting from this solicitation using full and open competition.


This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold of $350,000.00.


The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, seeks to award a Firm-Fixed-Price to the responsible offeror whose proposal represents the best value to the Government.


The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01 March 13, 2026.


The associated NAICS code is 541380, and the small business size standard is N/A.


This requirement is NOT A SET-ASIDE for small businesses.


Description of Requirement:


Medicinal Chemistry


The provision at FAR 52.212-1, Instructions to Offerors—Commercial Items, applies to this acquisition. Add any agency-specific instructions as required.


The provision at FAR 52.212-2, Evaluation—Commercial Items, applies to this acquisition.


The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation represents the best value to the Government, price and other factors considered.


Evaluation Factors:


  • Technical capability
  • Price
  • Past performance
  • Delivery schedule

A written notice of award or acceptance of an offer, issued within the time specified in the offer, shall result in a binding contract without further action by either party. The Government reserves the right to accept any offer before the expiration date.


Offerors shall include a completed copy of FAR 52.212-3, Offeror Representations and Certifications—Commercial Items, with their offer.


FAR 52.212-4, Contract Terms and Conditions—Commercial Items, applies to this acquisition.


FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders—Commercial Items, applies to this acquisition.


Submission Requirements:
Responses must include sufficient information to demonstrate the offeror’s capability to provide the required product or service. Quotes shall include, at a minimum:


  • Unit and total price
  • Shipping and handling costs
  • Delivery timeframe after award
  • Delivery terms
  • F.O.B. point (destination)
  • Product or catalog numbers (if applicable)
  • Product/service description

Additional evaluation considerations may include past performance, warranty, lifecycle cost, maintenance availability, and environmental or energy efficiency.


Responses must include the Unique Entity Identifier (UEI), Taxpayer Identification Number (TIN), and business size certification. All offerors must be actively registered in the System for Award Management (SAM) at www.sam.gov.


All responses must be received by August 10, 2026 at 9:00 AM and must reference solicitation number 75N98026Q00906. Responses may be submitted electronically to contact@example.gov.


Point of Contact:
James Law


contact@example.gov

More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao

Same awarding agency

NAICS: 519290
New
Federal
Access to Web of Science, EndNote and Incites
Solicitation # RFP-OD-04157
Solicitation RFP-OD-04157 is an unrestricted IDIQ contract opportunity issued by the National Institutes of Health Office of Logistics and Operations to provide NIH and HHS agency staff with access to the Web of Science product and desktop bibliographic management software. The scope of work includes access to various indices such as the Science Citation Index, Social Sciences Citation Index, and Journal Citation Reports, with requirements for weekly database updates and annual JCR updates. The bibliographic software must support 7,000 citation styles and allow for customized reference styles and automatic linking updates. Performance will take place in Bethesda, Maryland. The contract structure consists of a base year plus four option years, with an additional six-month extensional option. Award will be based on best value, considering price, technical proposal, organizational experience, past performance, and personnel availability. The government may select a higher-priced quote if the technical merit or lower performance risk justifies the premium. Proposals are due by November 4, 2026, and must include pricing for all options and completed representations and certifications per FAR 52.212-3. The procurement is categorized under NAICS code 519290 and is managed by Contracting Officer Lynda Cole.
Web Search Portals and All Other Information Services

POSTED

about 13 hours ago

DEADLINE

in 8 days
View Details
NAICS: 334516
New
Federal
CSS - Upgrading PExA 2.1 to Vial-Based (PExA Cap)
Solicitation # 75N98027Q00044
The National Institutes of Health (NIH), Office of the Director, is seeking a Firm-Fixed-Price purchase order under solicitation 75N98027Q00044 to upgrade a Government-owned PExA 2.1 instrument to PExA Cap functionality. This upgrade, intended for the Laboratory for Chronic Airway Infections, converts the existing paper-based collection mechanism to a vial-based system to eliminate post-collection substrate processing and improve analyte detectability. The scope of work includes the factory-level installation, servicing, and calibration of the instrument, the provision of 100 disposable sample kits, and a minimum one-year warranty. The contractor is also responsible for the fully insured, round-trip door-to-door transport of the sensitive scientific equipment between the contractor's facility and the NIH site in Bethesda, Maryland, using a carrier experienced in handling medical instrumentation. This unrestricted acquisition is conducted under FAR Subpart 12.6 for commercial items and is not expected to exceed the simplified acquisition threshold. The Government will award the contract based on best value, where technical capability, past performance, and delivery schedule are collectively considered significantly more important than price. While PExA AB of Gothenburg, Sweden is the brand name reference, the solicitation allows for equal products provided they meet all salient functional and performance characteristics. Proposals must be submitted by November 12, 2026, and must include the offeror's UEI, TIN, business size certification, and the country of origin for all supplies.
Analytical Laboratory Instrument Manufacturing

POSTED

about 13 hours ago

DEADLINE

in 14 days
View Details

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS